Yuichi Nishiyama

Dr. Yuichi Nishiyama

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2021 in Genes
Verified
Journal Article
Open access
PDF file
YNYuichi Nishiyama
Yuichi Nishiyama
Akinori MoritaAkinori Morita
Akinori Morita
STShogo Tatsuta
Shogo Tatsuta
MKMisaki Kanamaru
Misaki Kanamaru
SMSakaue Masahiro
Sakaue Masahiro
TSTakeshi Sugai
Takeshi Sugai
Flavonoids are a subclass of polyphenols which are attractive, due to possessing various physiological activities, including a radioprotective effect. Tumor suppressor p53 is a primary regulator in the radiation response and is involved in the pathogenesis of radiation injuries. In this study, we revealed that isorhamnetin inhibited radiation cell death, and investigated its action mechanism focusing on DNA damage response. Although isorhamnetin moderated p53 activity, it promoted phosphorylation of ataxia telangiectasia mutated (ATM) and enhanced 53BP1 recruitment in irradiated cells. The radioprotective effect of isorhamnetin was not observed in the presence of ATM inhibitor, indicating that its protective effect was dependent on ATM. Furthermore, isorhamnetin-treated mice survived gastrointestinal death caused by a lethal dose of abdominal irradiation. These findings suggested that isorhamnetin enhances the ATM-dependent DNA repair process, which is presumably associated with the suppressive effect against GI syndrome.

1 July 2021 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
YNYuichi Nishiyama
Yuichi Nishiyama
Akinori MoritaAkinori Morita
Akinori Morita
Bing WangBing Wang
Bing Wang
TSTakuma Sakai
Takuma Sakai
DRDwi Ramadhani
Dwi Ramadhani
SAShin Aoki
Shin Aoki
Our previous study indicated that sodium orthovanadate (vanadate), a strong inhibitor of p53, effectively suppressed the lethality from the hematopoietic (HP) and gastrointestinal (GI) syndromes af...

1 January 2004 in Journal of The Adhesion Society of Japan
Verified
Journal Article
Open access
YNYuichi Nishiyama
Yuichi Nishiyama
CSChiaki Sato
Chiaki Sato
NUNobuyuki Uto
Nobuyuki Uto
HIHiroyuki Ishikawa
Hiroyuki Ishikawa

1 November 2018 in Clinical Imaging
Verified
Journal Article
Closed access
HAHiroya Asou
Hiroya Asou
NINaoyuki Imada
Naoyuki Imada
YNYuichi Nishiyama
Yuichi Nishiyama
TSTomoyasu Sato
Tomoyasu Sato
KIKatsuhiro Ichikawa
Katsuhiro Ichikawa

15 October 2021 in Life
Verified
Journal Article
Open access
PDF file
Akinori MoritaAkinori Morita
Akinori Morita
SOShintaro Ochi
Shintaro Ochi
HSHidetoshi Satoh
Hidetoshi Satoh
SUShohei Ujita
Shohei Ujita
YMYosuke Matsushita
Yosuke Matsushita
Shin AokiShin Aoki
Shin Aoki
RNA synthesis inhibitors and protein synthesis inhibitors are useful for investigating whether biological events with unknown mechanisms require transcription or translation; however, the dependence of RNA synthesis has been difficult to verify because many RNA synthesis inhibitors cause adverse events that trigger a p53 response. In this study, we screened a library containing 9600 core compounds and obtained STK160830 that shows anti-apoptotic effects in irradiated wild-type-p53-bearing human T-cell leukemia MOLT-4 cells and murine thymocytes. In many of the p53-impaired cells and p53-knockdown cells tested, STK160830 did not show a remarkable anti-apoptotic effect, suggesting that the anti-apoptotic activity is p53-dependent. In the expression analysis of p53, p53-target gene products, and reference proteins by immunoblotting, STK160830 down-regulated the expression of many of the proteins examined, and the downregulation correlated strongly with its inhibitory effect on cell death. mRNA expression analyses by qPCR and nascent RNA capture kit revealed that STK160830 showed a decreased mRNA expression, which was similar to that induced by the RNA synthesis inhibitor actinomycin D but differed to some extent. Furthermore, unlike other RNA synthesis inhibitors such as actinomycin D, p53 accumulation by STK160830 alone was negligible, and a DNA melting-curve analysis showed very weak DNA-intercalating activity, indicating that STK160830 is a useful inhibitor for RNA synthesis without triggering p53-mediated damage responses.

30 October 2021 in Radiological Physics and Technology
Verified
Journal Article
Closed access
PDF file
MTMasahide Tominaga
Masahide Tominaga
YNYukari Nagayasu
Yukari Nagayasu
MSMotoharu Sasaki
Motoharu Sasaki
TFTakuya Furuta
Takuya Furuta
HHHiroaki Hayashi
Hiroaki Hayashi
AHAkihiro Haga
Akihiro Haga